PGP-4008 (CAS 365565-02-2)
See product citations (1)
QUICK LINKS
PGP-4008 is a chemical compound recognized for its specificity as a P-glycoprotein (Pgp) inhibitor, which is of great significance in biochemical and molecular pharmacology. Its ability to selectively inhibit Pgp is in studies aiming to identify the role of this efflux transporter in the cellular export of various substances. Studies involving PGP-4008 focuses on understanding the molecular mechanisms of Pgp and its interaction with inhibitors. The compound is also applied in the study of multi-chemical interactions and the modulation of Pgp activity, which has implications for the distribution and accumulation of compounds within tissues. PGP-4008 is in the characterization of substrate specificity and the transport kinetics of Pgp, providing insights into the design of molecules capable of bypassing efflux mechanisms.
PGP-4008 (CAS 365565-02-2) References
- Synthesis and evaluation of dihydropyrroloquinolines that selectively antagonize P-glycoprotein. | Lee, BD., et al. 2004. J Med Chem. 47: 1413-22. PMID: 14998330
- Evaluation of the role of P-glycoprotein in the uptake of paroxetine, clozapine, phenytoin and carbamazapine by bovine retinal endothelial cells. | Maines, LW., et al. 2005. Neuropharmacology. 49: 610-7. PMID: 15961125
- The multidrug transporter hypothesis of refractory epilepsy: corroboration and contradiction in equal measure. | Sills, GJ. 2006. Epilepsy Curr. 6: 51-4. PMID: 16604202
- Role of P-glycoprotein in cyclosporine cytotoxicity in the cyclosporine-sirolimus interaction. | Anglicheau, D., et al. 2006. Kidney Int. 70: 1019-25. PMID: 16837925
- Both P-gp and MRP2 mediate transport of Lopinavir, a protease inhibitor. | Agarwal, S., et al. 2007. Int J Pharm. 339: 139-47. PMID: 17451894
- Molecular expression and functional evidence of a drug efflux pump (BCRP) in human corneal epithelial cells. | Karla, PK., et al. 2009. Curr Eye Res. 34: 1-9. PMID: 19172464
- Inhibition of P-glycoprotein-mediated docetaxel efflux sensitizes ovarian cancer cells to concomitant docetaxel and SN-38 exposure. | Miettinen, S., et al. 2009. Anticancer Drugs. 20: 267-76. PMID: 19262372
- Contribution of aquaporin 9 and multidrug resistance-associated protein 2 to differential sensitivity to arsenite between primary cultured chorion and amnion cells prepared from human fetal membranes. | Yoshino, Y., et al. 2011. Toxicol Appl Pharmacol. 257: 198-208. PMID: 21945491
- P-glycoprotein expression in Perna viridis after exposure to Prorocentrum lima, a dinoflagellate producing DSP toxins. | Huang, L., et al. 2014. Fish Shellfish Immunol. 39: 254-62. PMID: 24811006
- Association between acquired resistance to PLX4032 (vemurafenib) and ATP-binding cassette transporter expression. | Michaelis, M., et al. 2014. BMC Res Notes. 7: 710. PMID: 25300205
- CX3CR1 identifies PD-1 therapy-responsive CD8+ T cells that withstand chemotherapy during cancer chemoimmunotherapy. | Yan, Y., et al. 2018. JCI Insight. 3: PMID: 29669928
- A Machine Learning-Based Prediction Platform for P-Glycoprotein Modulators and Its Validation by Molecular Docking. | Kadioglu, O. and Efferth, T. 2019. Cells. 8: PMID: 31640190
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
PGP-4008, 2 mg | sc-222152 | 2 mg | $107.00 | |||
PGP-4008, 10 mg | sc-222152A | 10 mg | $349.00 |